Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis.
Paracoccidioidomycosis (PCM), caused by Paracoccidioides brasiliensis, is the most prevalent invasive fungal disease in South America. Systemic mycoses are the 10th most common cause of death among infectious diseases in Brazil and PCM is responsible for more than 50% of deaths due to fungal infecti...
Main Authors: | Glauce M G Rittner, Julián E Muñoz, Alexandre F Marques, Joshua D Nosanchuk, Carlos P Taborda, Luiz R Travassos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3289603?pdf=render |
Similar Items
-
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
by: Leandro B. R. Silva, et al.
Published: (2017-06-01) -
The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide
by: Oriana eMayorga, et al.
Published: (2012-05-01) -
Neutrophil Cells Are Essential for The Efficacy of a Therapeutic Vaccine against Paracoccidioidomycosis
by: Lucas dos Santos Dias, et al.
Published: (2021-05-01) -
PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS
by: Carlos. P. TABORDA, et al.
Published: (2015-09-01) -
Intranasal Vaccine Using P10 Peptide Complexed within Chitosan Polymeric Nanoparticles as Experimental Therapy for Paracoccidioidomycosis in Murine Model
by: Samuel Rodrigues Dos Santos Junior, et al.
Published: (2020-09-01)